SuzanneMacFarlandMD
Pediatric Hematology & Oncology • Philadelphia, PAAssistant Professor, Pediatrics, Perelman School of Medicine, Division of Oncology
Overview of Dr. MacFarland
Dr. Suzanne MacFarland is a pediatric hematologist/oncologist in Philadelphia, PA and is affiliated with Children's Hospital of Philadelphia. She received her medical degree from New York University Grossman School of Medicine and has been in practice 10 years. She is one of 166 doctors at Children's Hospital of Philadelphia who specialize in Pediatric Hematology & Oncology. She has more than 10 publications and 26 citings.
Office
3401 Civic Center Blvd
Philadelphia, PA 19104
Education & Training
Children's Hospital of PhiladelphiaResidency, Pediatrics, 2011 - 2014
New York University School of MedicineClass of 2011
Certifications & Licensure
FL State Medical License 2021 - Present
DE State Medical License 2022 - 2025
MD State Medical License 2021 - 2025
NC State Medical License 2021 - 2025
NJ State Medical License 2022 - 2025
PA State Medical License 2011 - 2024
VA State Medical License 2022 - 2024- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
- Join now to see all
Clinical Trials
- Educational Video for Genetic Testing Start of enrollment: 2021 Sep 10
Roles: Principal Investigator, Contact
- Care Plans for Cancer Predisposition Start of enrollment: 2023 Aug 25
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 3 citationsIdentification of TP53 germline variants in pediatric patients undergoing tumor testing: strategy and prevalence.Minjie Luo, Derek Wong, Kristin Zelley, Jinhua Wu, Jeffery Schubert
Journal of the National Cancer Institute. 2024-08-01 - 5 citationsAlternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatc...Jennifer L Stundon, Heba Ijaz, Krutika S Gaonkar, Rebecca S Kaufman, Run Jin
Neuro-Oncology. 2023-07-06 - 1 citationsJuvenile polyposis without a germline variant in SMAD4/BMPR1A: defining a clinically distinct polyposis syndrome.Suzanne P. MacFarland, Bryson W. Katona
Oncotarget. 2021-08-31
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
